Back to results

GLP-1 Dementia, Alzheimer’s Disease Risks Questioned in New Study

via AboutLawsuits Published: Apr 27, 2026

Summary

A new study finds cognitive decline in patients taking GLP-1 medications for longer than 10 years, yet researchers say it may be the result of those patients living longer than their peers.

Read full article →